MedTrace Logo

Safety and Efficacy of Using GlucoSat Technology For Non-Invasive Glucose Measurement

NCT00451334 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2007-03-23

No results posted yet for this study

Summary

This study is a prospective, open label, controlled, single center study. 40 patients will be recruited for the study, according to patients' inflow and meeting eligibility criteria.

Primary Goal

\* To evaluate the safety of the GlucoSat technology as a non-invasive blood glucose level measurement technology.

Secondary Goal

\* To assess the efficacy of the GlucoSat technology as a non-invasive blood glucose level measurement technology.

Conditions

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    lead OTHER_GOV

Principal Investigators

  • Shai Efrati, MD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • Israel

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00451334 on ClinicalTrials.gov